![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-4063|9|3|172-180
ISSN: 1871-529X
Source: Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.9, Iss.3, 2009-09, pp. : 172-180
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PI3K/AKT signaling and systemic autoimmunity
Immunologic Research, Vol. 31, Iss. 1, 2005-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Liu Hong Mihara Keichiro Song Guoqi Tanaka Hideo Kimura Akiro
Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kato S. Yamaguchi M. Fujii T. Miyagi N. Terasaki M. Hamada T. Sugita Y. Morimatsu M.
Experimental and Molecular Pathology, Vol. 66, Iss. 1, 1999-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PI3K and negative regulation of TLR signaling
Trends in Immunology, Vol. 24, Iss. 7, 2003-07 ,pp. :